This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
LentiCRISPR v2 RB1 sgRNA #2
catalog :
202519
citations: 1
Reference
Wang M, Chen J, Lu Y, Bawcom A, Wu J, Ou J, et al. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. J Clin Invest. 2023;133: pubmed publisher
product information
Catalog Number :
202519
Product Name :
LentiCRISPR v2 RB1 sgRNA #2
article :
doi10.1172/JCI166647
id28237969
pubmed_id36928314
bacterial resistance :
Ampicillin
cloning :
backboneLentiCRISPR v2
backbone_mutation
backbone_origin
backbone_size14873
promoter
sequencing_primer_3
sequencing_primer_5
vector_types
Mammalian Expression
Lentiviral
CRISPR
growth strain :
Expressing Cas9 and sgRNA targeting human RB1 gene
origin :
37
pi :
alt_names
cloning
clone_methodRestriction Enzyme
cloning_site_3BsmBI
cloning_site_5BsmBI
promoterU6
sequencing_primer_3
sequencing_primer_5U6
site_3_destroyed1
site_5_destroyed1
entrez_gene
aliasesOSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb, pp110
geneRB1
id5925
genbank_ids
NM_000321.3
mutation
nameRB1 sgRNA
shRNA_sequenceGGTTCTTTGAGCAACATGGG
size
species
9606
Homo sapiens
tags
resistance markers :
6513
tags :
Unknown
terms :
Puromycin
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
info@addgene.org
https://www.addgene.org
617.225.9000
headquarters: USA